Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.
暂无分享，去创建一个
T. Ottenhoff | J. McClain | P. Andersen | T. Vesikari | J. Andersson | M. Maeurer | S. Brighenti | R. Ahmed | S. Mahdavifar | M. Norrby | L. Lindqvist | Sean R Bennett | B. Shepherd | D. Li | D. Hokey | Ingrid Kromann | S. Hoff | A. W. de Visser | S. Joosten | Daner Li | Sean Bennett | Barbara Shepherd